Skip to main content
Premium Trial:

Request an Annual Quote

Wendell Wierenga, Daniel Gold, Craig Venter, Matthew Trunnell, Dennis Bittner


Ciphergen has appointed Wendell Wierenga, CEO of Syrrx, to its board of directors. Wierenga joined Syrrx as CEO in September 2000, and in previous positions has served as a senior vice president for worldwide pharmaceutical sciences, technology, and development at Pfizer, and as senior vice president of the Parke-Davis Pharmaceutical Research division of Warner-Lambert.

Daniel Gold has joined Human Genome Sciences as senior vice president for process development, the company said last week. In his new position, Gold will be responsible for overseeing the development of manufacturing processes for the production of therapeutic proteins and antibody drugs. In his most recent position, Gold served as vice president for process development and chief scientific officer of Diosynth-RTP, a contract biopharmaceutical process development and manufacturing division of Akzo Nobel. He will report to Craig Rosen, HGS' executive vice president for research and development.

Woburn, Mass.-based U.S. Genomics has appointed Craig Venter to its board of directors and named him as a scientific advisor, the company said last week. This is Venter's first such job in a private-sector setting since leaving Celera Genomics in January.

Matthew Trunnell has joined GeneData of South San Francisco as head of technology for the company’s West Coast office. Dennis Bittner has also joined the company as director of marketing.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.